FDA
approval
· 2022-08-18
FDA Approved: SAPROPTERIN DIHYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved Camber Pharmaceuticals' original application for sapropterin dihydrochloride, a generic version of the PKU therapy. This action expands access to t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SAPROPTERIN DIHYDROCHLORIDE (SAPROPTERIN DIHYDROCHLORIDE)